BMC Clinical Pharmacology

unofficial impact factor 1.36

Open Access Email this article to a friend

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results

James B Adams*, Matthew Baral, Elizabeth Geis, Jessica Mitchell, Julie Ingram, Andrea Hensley, Irene Zappia, Sanford Newmark, Eva Gehn, Robert A Rubin, Ken Mitchell, Jeff Bradstreet and Jane El-Dahr

BMC Clinical Pharmacology 2009, 9:17 doi:10.1186/1472-6904-9-17

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.